Effect of Folic Acid on Bone Metabolism: A Randomized Double Blind Clinical Trial in Postmenopausal osteoporosis Wome
Phase 2
- Conditions
- Osteoporosis.Senile Osteoporosis
- Registration Number
- IRCT2014042217385N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria: Age= 50-60yrs; Postmenopausal Women; Osteoporosis.
Exclusion Criteria
History of Cancer; Acute Infection; Endocrinologic Diseases; Taking Medicines Affecting Bone Metabolism Such As Corticosteroids;Gonadotropine Releasing Hormone (GnRH) Analogues; Anticonvulsant Drugs; Heparin; Aluminum Containing Antacids; Thyroid Hormones.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pyridinoline. Timepoint: At Baseline, 3 and 6 Months Later. Method of measurement: µg/mmol cr.;Osteocalcin. Timepoint: At Baseline, 3 and 6 Months Later. Method of measurement: ng/ml.;Bone Alkaline Phosphatase. Timepoint: At Baseline, 3 and 6 Months Later. Method of measurement: U/L.;U ß Cross Laps. Timepoint: At Baseline, 3 and 6 Months Later. Method of measurement: µg/mmol cr.;Bone density. Timepoint: Before. Method of measurement: Gm/cm2.
- Secondary Outcome Measures
Name Time Method